Compile Data Set for Download or QSAR
Report error Found 99 Enz. Inhib. hit(s) with all data for entry = 50046857
TargetGastrin/cholecystokinin type B receptor(Human)
Mayo Clinic

Curated by ChEMBL
LigandPNGBDBM50380728(CHEMBL2017835)
Affinity DataEC50: <1.00E+3nMAssay Description:Agonist activity at human CCK2R H7.39L mutant expressed in CHO cells assessed as intracellular calcium response by fluorescence analysisMore data for this Ligand-Target Pair
In Depth
Date in BDB:
5/24/2017
Entry Details Article
PubMed
TargetGastrin/cholecystokinin type B receptor(Human)
Mayo Clinic

Curated by ChEMBL
LigandPNGBDBM50329179(2-((4S)-4-((1H-indol-3-yl)methyl)-5-oxo-1-phenyl-4...)
Affinity DataEC50: <1.00E+3nMAssay Description:Agonist activity at human CCK2R T2.61N mutant expressed in CHO cells assessed as intracellular calcium response by fluorescence analysisMore data for this Ligand-Target Pair
In Depth
Date in BDB:
5/24/2017
Entry Details Article
PubMed
TargetCholecystokinin receptor type A(Human)
Mayo Clinic

Curated by ChEMBL
LigandPNGBDBM50329179(2-((4S)-4-((1H-indol-3-yl)methyl)-5-oxo-1-phenyl-4...)
Affinity DataEC50:  42nMAssay Description:Agonist activity at human CCK1R I6.51V, F6.52Y mutant expressed in CHO cells assessed as intracellular calcium response by fluorescence analysisMore data for this Ligand-Target Pair
In Depth
Date in BDB:
5/24/2017
Entry Details Article
PubMed
TargetCholecystokinin receptor type A(Human)
Mayo Clinic

Curated by ChEMBL
LigandPNGBDBM50329179(2-((4S)-4-((1H-indol-3-yl)methyl)-5-oxo-1-phenyl-4...)
Affinity DataEC50:  1.40nMAssay Description:Agonist activity at human CCK1R T3.28V, T3.29S mutant expressed in CHO cells assessed as intracellular calcium response by fluorescence analysisMore data for this Ligand-Target Pair
In Depth
Date in BDB:
5/24/2017
Entry Details Article
PubMed
TargetCholecystokinin receptor type A(Human)
Mayo Clinic

Curated by ChEMBL
LigandPNGBDBM50329179(2-((4S)-4-((1H-indol-3-yl)methyl)-5-oxo-1-phenyl-4...)
Affinity DataEC50:  0.525nMAssay Description:Agonist activity at human CCK1R N2.61T mutant expressed in CHO cells assessed as intracellular calcium response by fluorescence analysisMore data for this Ligand-Target Pair
In Depth
Date in BDB:
5/24/2017
Entry Details Article
PubMed
TargetGastrin/cholecystokinin type B receptor(Human)
Mayo Clinic

Curated by ChEMBL
LigandPNGBDBM50329179(2-((4S)-4-((1H-indol-3-yl)methyl)-5-oxo-1-phenyl-4...)
Affinity DataEC50: <1.00E+3nMAssay Description:Agonist activity at human CCK2R V3.28T, S3.29T mutant expressed in CHO cells assessed as intracellular calcium response by fluorescence analysisMore data for this Ligand-Target Pair
In Depth
Date in BDB:
5/24/2017
Entry Details Article
PubMed
TargetCholecystokinin receptor type A(Human)
Mayo Clinic

Curated by ChEMBL
LigandPNGBDBM50380728(CHEMBL2017835)
Affinity DataEC50:  0.288nMAssay Description:Agonist activity at human CCK1R N2.61T mutant expressed in CHO cells assessed as intracellular calcium response by fluorescence analysisMore data for this Ligand-Target Pair
In Depth
Date in BDB:
5/24/2017
Entry Details Article
PubMed
TargetCholecystokinin receptor type A(Human)
Mayo Clinic

Curated by ChEMBL
LigandPNGBDBM50380728(CHEMBL2017835)
Affinity DataEC50:  0.120nMAssay Description:Agonist activity at human CCK1R T3.28V, T3.29S mutant expressed in CHO cells assessed as intracellular calcium response by fluorescence analysisMore data for this Ligand-Target Pair
In Depth
Date in BDB:
5/24/2017
Entry Details Article
PubMed
TargetCholecystokinin receptor type A(Human)
Mayo Clinic

Curated by ChEMBL
LigandPNGBDBM50329179(2-((4S)-4-((1H-indol-3-yl)methyl)-5-oxo-1-phenyl-4...)
Affinity DataEC50:  1.51nMAssay Description:Agonist activity at wild-type human CCK1R expressed in CHO cells assessed as intracellular calcium response by fluorescence analysisMore data for this Ligand-Target Pair
In Depth
Date in BDB:
5/24/2017
Entry Details Article
PubMed
TargetCholecystokinin receptor type A(Human)
Mayo Clinic

Curated by ChEMBL
LigandPNGBDBM50329179(2-((4S)-4-((1H-indol-3-yl)methyl)-5-oxo-1-phenyl-4...)
Affinity DataEC50:  1.5nMAssay Description:Agonist activity at wild-type human CCK1R expressed in CHO cells assessed as intracellular calcium response by fluorescence analysisMore data for this Ligand-Target Pair
In Depth
Date in BDB:
5/24/2017
Entry Details Article
PubMed
TargetGastrin/cholecystokinin type B receptor(Human)
Mayo Clinic

Curated by ChEMBL
LigandPNGBDBM50329179(2-((4S)-4-((1H-indol-3-yl)methyl)-5-oxo-1-phenyl-4...)
Affinity DataEC50:  1.00E+3nMAssay Description:Partial agonist activity at wild-type human CCK2R expressed in CHO cells assessed as intracellular calcium response by fluorescence analysisMore data for this Ligand-Target Pair
In Depth
Date in BDB:
5/24/2017
Entry Details Article
PubMed
TargetGastrin/cholecystokinin type B receptor(Human)
Mayo Clinic

Curated by ChEMBL
LigandPNGBDBM50329179(2-((4S)-4-((1H-indol-3-yl)methyl)-5-oxo-1-phenyl-4...)
Affinity DataEC50:  977nMAssay Description:Partial agonist activity at wild-type human CCK2R expressed in CHO cells assessed as intracellular calcium response by fluorescence analysisMore data for this Ligand-Target Pair
In Depth
Date in BDB:
5/24/2017
Entry Details Article
PubMed
TargetGastrin/cholecystokinin type B receptor(Human)
Mayo Clinic

Curated by ChEMBL
LigandPNGBDBM50329179(2-((4S)-4-((1H-indol-3-yl)methyl)-5-oxo-1-phenyl-4...)
Affinity DataEC50:  282nMAssay Description:Agonist activity at human CCK2R V6.51I, Y6.52F mutant expressed in CHO cells assessed as intracellular calcium response by fluorescence analysisMore data for this Ligand-Target Pair
In Depth
Date in BDB:
5/24/2017
Entry Details Article
PubMed
TargetCholecystokinin receptor type A(Human)
Mayo Clinic

Curated by ChEMBL
LigandPNGBDBM50380728(CHEMBL2017835)
Affinity DataEC50:  69nMAssay Description:Agonist activity at human CCK1R I6.51V, F6.52Y mutant expressed in CHO cells assessed as intracellular calcium response by fluorescence analysisMore data for this Ligand-Target Pair
In Depth
Date in BDB:
5/24/2017
Entry Details Article
PubMed
TargetCholecystokinin receptor type A(Human)
Mayo Clinic

Curated by ChEMBL
LigandPNGBDBM50380728(CHEMBL2017835)
Affinity DataEC50: <100nMAssay Description:Agonist activity at human CCK1R L7.39H mutant expressed in CHO cells assessed as intracellular calcium response by fluorescence analysisMore data for this Ligand-Target Pair
In Depth
Date in BDB:
5/24/2017
Entry Details Article
PubMed
TargetGastrin/cholecystokinin type B receptor(Human)
Mayo Clinic

Curated by ChEMBL
LigandPNGBDBM50380728(CHEMBL2017835)
Affinity DataEC50: <1.00E+3nMAssay Description:Agonist activity at human CCK2R V6.51I, Y6.52F mutant expressed in CHO cells assessed as intracellular calcium response by fluorescence analysisMore data for this Ligand-Target Pair
In Depth
Date in BDB:
5/24/2017
Entry Details Article
PubMed
TargetCholecystokinin receptor type A(Human)
Mayo Clinic

Curated by ChEMBL
LigandPNGBDBM50380728(CHEMBL2017835)
Affinity DataEC50:  0.470nMAssay Description:Agonist activity at wild-type human CCK1R expressed in CHO cells assessed as intracellular calcium response by fluorescence analysisMore data for this Ligand-Target Pair
In Depth
Date in BDB:
5/24/2017
Entry Details Article
PubMed
TargetGastrin/cholecystokinin type B receptor(Human)
Mayo Clinic

Curated by ChEMBL
LigandPNGBDBM50329179(2-((4S)-4-((1H-indol-3-yl)methyl)-5-oxo-1-phenyl-4...)
Affinity DataEC50:  59nMAssay Description:Agonist activity at human CCK2R H7.39L mutant expressed in CHO cells assessed as intracellular calcium response by fluorescence analysisMore data for this Ligand-Target Pair
In Depth
Date in BDB:
5/24/2017
Entry Details Article
PubMed
TargetCholecystokinin receptor type A(Human)
Mayo Clinic

Curated by ChEMBL
LigandPNGBDBM50380728(CHEMBL2017835)
Affinity DataEC50:  0.470nMAssay Description:Agonist activity at wild-type human CCK1R expressed in CHO cells assessed as intracellular calcium response by fluorescence analysisMore data for this Ligand-Target Pair
In Depth
Date in BDB:
5/24/2017
Entry Details Article
PubMed
TargetCholecystokinin receptor type A(Human)
Mayo Clinic

Curated by ChEMBL
LigandPNGBDBM50380728(CHEMBL2017835)
Affinity DataEC50:  5nMAssay Description:Agonist activity at human CCK1R W6.48A mutant expressed in CHO cells assessed as intracellular calcium response by fluorescence analysisMore data for this Ligand-Target Pair
In Depth
Date in BDB:
5/24/2017
Entry Details Article
PubMed
TargetCholecystokinin receptor type A(Human)
Mayo Clinic

Curated by ChEMBL
LigandPNGBDBM50380728(CHEMBL2017835)
Affinity DataEC50:  3.30nMAssay Description:Agonist activity at human CCK1R V3.36A mutant expressed in CHO cells assessed as intracellular calcium response by fluorescence analysisMore data for this Ligand-Target Pair
In Depth
Date in BDB:
5/24/2017
Entry Details Article
PubMed
TargetCholecystokinin receptor type A(Human)
Mayo Clinic

Curated by ChEMBL
LigandPNGBDBM50380728(CHEMBL2017835)
Affinity DataIC50: 0.813nMAssay Description:Displacement of [125I-CCK] from human CCK1R N2.61T mutant expressed in CHO cells after 60 mins by scintillation counterMore data for this Ligand-Target Pair
In Depth
Date in BDB:
5/24/2017
Entry Details Article
PubMed
TargetCholecystokinin receptor type A(Human)
Mayo Clinic

Curated by ChEMBL
LigandPNGBDBM50380728(CHEMBL2017835)
Affinity DataIC50: 1.40nMAssay Description:Displacement of [125I-CCK] from human CCK1R W6.48A mutant expressed in CHO cells after 60 mins by scintillation counterMore data for this Ligand-Target Pair
In Depth
Date in BDB:
5/24/2017
Entry Details Article
PubMed
TargetGastrin/cholecystokinin type B receptor(Human)
Mayo Clinic

Curated by ChEMBL
LigandPNGBDBM50329179(2-((4S)-4-((1H-indol-3-yl)methyl)-5-oxo-1-phenyl-4...)
Affinity DataIC50: 1.70nMAssay Description:Displacement of [125I-CCK] from human CCK2R H7.39L mutant expressed in CHO cells after 60 mins by scintillation counterMore data for this Ligand-Target Pair
In Depth
Date in BDB:
5/24/2017
Entry Details Article
PubMed
TargetGastrin/cholecystokinin type B receptor(Human)
Mayo Clinic

Curated by ChEMBL
LigandPNGBDBM50329179(2-((4S)-4-((1H-indol-3-yl)methyl)-5-oxo-1-phenyl-4...)
Affinity DataIC50: 2nMAssay Description:Displacement of [125I-BDZ-2] from human CCK2R H7.39L mutant expressed in CHO cells after 60 mins by scintillation counterMore data for this Ligand-Target Pair
In Depth
Date in BDB:
5/24/2017
Entry Details Article
PubMed
TargetCholecystokinin receptor type A(Human)
Mayo Clinic

Curated by ChEMBL
LigandPNGBDBM50329179(2-((4S)-4-((1H-indol-3-yl)methyl)-5-oxo-1-phenyl-4...)
Affinity DataIC50: 2nMAssay Description:Displacement of [125I-CCK] from human CCK1R N2.61T mutant expressed in CHO cells after 60 mins by scintillation counterMore data for this Ligand-Target Pair
In Depth
Date in BDB:
5/24/2017
Entry Details Article
PubMed
TargetCholecystokinin receptor type A(Human)
Mayo Clinic

Curated by ChEMBL
LigandPNGBDBM50329179(2-((4S)-4-((1H-indol-3-yl)methyl)-5-oxo-1-phenyl-4...)
Affinity DataIC50: 3.10nMAssay Description:Agonist activity at human CCK1R V3.36A mutant expressed in CHO cells assessed as intracellular calcium response by fluorescence analysisMore data for this Ligand-Target Pair
In Depth
Date in BDB:
5/24/2017
Entry Details Article
PubMed
TargetCholecystokinin receptor type A(Human)
Mayo Clinic

Curated by ChEMBL
LigandPNGBDBM50329179(2-((4S)-4-((1H-indol-3-yl)methyl)-5-oxo-1-phenyl-4...)
Affinity DataIC50: 4.5nMAssay Description:Displacement of [125I-BDZ-1] from human CCK1R T3.28V, T3.29S mutant expressed in CHO cells after 60 mins by scintillation counterMore data for this Ligand-Target Pair
In Depth
Date in BDB:
5/24/2017
Entry Details Article
PubMed
TargetCholecystokinin receptor type A(Human)
Mayo Clinic

Curated by ChEMBL
LigandPNGBDBM50380728(CHEMBL2017835)
Affinity DataIC50: 7.20nMAssay Description:Displacement of [125I-BDZ-1] from human CCK1R T3.28V, T3.29S mutant expressed in CHO cells after 60 mins by scintillation counterMore data for this Ligand-Target Pair
In Depth
Date in BDB:
5/24/2017
Entry Details Article
PubMed
TargetGastrin/cholecystokinin type B receptor(Human)
Mayo Clinic

Curated by ChEMBL
LigandPNGBDBM50380728(CHEMBL2017835)
Affinity DataIC50: 7.60nMAssay Description:Displacement of [125I-CCK] from human CCK2R H7.39L mutant expressed in CHO cells after 60 mins by scintillation counterMore data for this Ligand-Target Pair
In Depth
Date in BDB:
5/24/2017
Entry Details Article
PubMed
TargetGastrin/cholecystokinin type B receptor(Human)
Mayo Clinic

Curated by ChEMBL
LigandPNGBDBM50380728(CHEMBL2017835)
Affinity DataIC50: 10nMAssay Description:Displacement of [125I-BDZ-2] from human CCK2R H7.39L mutant expressed in CHO cells after 60 mins by scintillation counterMore data for this Ligand-Target Pair
In Depth
Date in BDB:
5/24/2017
Entry Details Article
PubMed
TargetCholecystokinin receptor type A(Human)
Mayo Clinic

Curated by ChEMBL
LigandPNGBDBM50380728(CHEMBL2017835)
Affinity DataIC50: 10nMAssay Description:Displacement of [125I-CCK] from human CCK1R V3.36A mutant expressed in CHO cells after 60 mins by scintillation counterMore data for this Ligand-Target Pair
In Depth
Date in BDB:
5/24/2017
Entry Details Article
PubMed
TargetCholecystokinin receptor type A(Human)
Mayo Clinic

Curated by ChEMBL
LigandPNGBDBM50329179(2-((4S)-4-((1H-indol-3-yl)methyl)-5-oxo-1-phenyl-4...)
Affinity DataIC50: 15nMAssay Description:Displacement of [125I-BDZ-1] from human CCK1R M3.32A mutant expressed in CHO cells after 60 mins by scintillation counterMore data for this Ligand-Target Pair
In Depth
Date in BDB:
5/24/2017
Entry Details Article
PubMed
TargetCholecystokinin receptor type A(Human)
Mayo Clinic

Curated by ChEMBL
LigandPNGBDBM50329179(2-((4S)-4-((1H-indol-3-yl)methyl)-5-oxo-1-phenyl-4...)
Affinity DataIC50: 17nMAssay Description:Displacement of [125I-CCK] from human CCK1R V3.36A mutant expressed in CHO cells after 60 mins by scintillation counterMore data for this Ligand-Target Pair
In Depth
Date in BDB:
5/24/2017
Entry Details Article
PubMed
LigandPNGBDBM50380728(CHEMBL2017835)
Affinity DataIC50: 17nMAssay Description:Displacement of [125I]-BDZ-1 from rat CCK1R Ala-317,321,325 non dimerizing mutant expressed in COS cells after 60 mins by scintillation counterMore data for this Ligand-Target Pair
In Depth
Date in BDB:
5/24/2017
Entry Details Article
PubMed
TargetCholecystokinin receptor type A(Human)
Mayo Clinic

Curated by ChEMBL
LigandPNGBDBM50329179(2-((4S)-4-((1H-indol-3-yl)methyl)-5-oxo-1-phenyl-4...)
Affinity DataIC50: 22nMAssay Description:Displacement of [125I-CCK] from wild-type human CCK1R expressed in CHO cells after 60 mins by scintillation counterMore data for this Ligand-Target Pair
In Depth
Date in BDB:
5/24/2017
Entry Details Article
PubMed
TargetCholecystokinin receptor type A(Human)
Mayo Clinic

Curated by ChEMBL
LigandPNGBDBM50329179(2-((4S)-4-((1H-indol-3-yl)methyl)-5-oxo-1-phenyl-4...)
Affinity DataIC50: 22.4nMAssay Description:Displacement of [125I-CCK] from wild-type human CCK1R expressed in CHO cells after 60 mins by scintillation counterMore data for this Ligand-Target Pair
In Depth
Date in BDB:
5/24/2017
Entry Details Article
PubMed
LigandPNGBDBM50329179(2-((4S)-4-((1H-indol-3-yl)methyl)-5-oxo-1-phenyl-4...)
Affinity DataIC50: 25nMAssay Description:Displacement of [125I]-BDZ-1 from rat CCK1R Ala-317,321,325 non dimerizing mutant expressed in COS cells after 60 mins by scintillation counterMore data for this Ligand-Target Pair
In Depth
Date in BDB:
5/24/2017
Entry Details Article
PubMed
TargetCholecystokinin receptor type A(Human)
Mayo Clinic

Curated by ChEMBL
LigandPNGBDBM50380728(CHEMBL2017835)
Affinity DataIC50: 35nMAssay Description:Displacement of [125I-CCK] from wild-type human CCK1R expressed in CHO cells after 60 mins by scintillation counterMore data for this Ligand-Target Pair
In Depth
Date in BDB:
5/24/2017
Entry Details Article
PubMed
TargetCholecystokinin receptor type A(Human)
Mayo Clinic

Curated by ChEMBL
LigandPNGBDBM50380728(CHEMBL2017835)
Affinity DataIC50: 35nMAssay Description:Displacement of [125I-CCK] from wild-type human CCK1R expressed in CHO cells after 60 mins by scintillation counterMore data for this Ligand-Target Pair
In Depth
Date in BDB:
5/24/2017
Entry Details Article
PubMed
TargetCholecystokinin receptor type A(Human)
Mayo Clinic

Curated by ChEMBL
LigandPNGBDBM50329179(2-((4S)-4-((1H-indol-3-yl)methyl)-5-oxo-1-phenyl-4...)
Affinity DataIC50: 37nMAssay Description:Displacement of [125I-CCK] from human CCK1R T3.28V, T3.29S mutant expressed in CHO cells after 60 mins by scintillation counterMore data for this Ligand-Target Pair
In Depth
Date in BDB:
5/24/2017
Entry Details Article
PubMed
TargetCholecystokinin receptor type A(Human)
Mayo Clinic

Curated by ChEMBL
LigandPNGBDBM50329179(2-((4S)-4-((1H-indol-3-yl)methyl)-5-oxo-1-phenyl-4...)
Affinity DataIC50: 42nMAssay Description:Displacement of [125I-CCK] from human CCK1R W6.48A mutant expressed in CHO cells after 60 mins by scintillation counterMore data for this Ligand-Target Pair
In Depth
Date in BDB:
5/24/2017
Entry Details Article
PubMed
TargetCholecystokinin receptor type A(Human)
Mayo Clinic

Curated by ChEMBL
LigandPNGBDBM50380728(CHEMBL2017835)
Affinity DataIC50: 43nMAssay Description:Displacement of [125I-CCK] from human CCK1R T3.28V, T3.29S mutant expressed in CHO cells after 60 mins by scintillation counterMore data for this Ligand-Target Pair
In Depth
Date in BDB:
5/24/2017
Entry Details Article
PubMed
TargetCholecystokinin receptor type A(Human)
Mayo Clinic

Curated by ChEMBL
LigandPNGBDBM50329179(2-((4S)-4-((1H-indol-3-yl)methyl)-5-oxo-1-phenyl-4...)
Affinity DataIC50: 43nMAssay Description:Displacement of [125I-CCK] from human CCK1R I6.51V, F6.52Y mutant expressed in CHO cells after 60 mins by scintillation counterMore data for this Ligand-Target Pair
In Depth
Date in BDB:
5/24/2017
Entry Details Article
PubMed
TargetCholecystokinin receptor type A(Human)
Mayo Clinic

Curated by ChEMBL
LigandPNGBDBM50380728(CHEMBL2017835)
Affinity DataIC50: 62nMAssay Description:Displacement of [125I-BDZ-1] from human CCK1R W6.48A mutant expressed in CHO cells after 60 mins by scintillation counterMore data for this Ligand-Target Pair
In Depth
Date in BDB:
5/24/2017
Entry Details Article
PubMed
TargetCholecystokinin receptor type A(Human)
Mayo Clinic

Curated by ChEMBL
LigandPNGBDBM50380728(CHEMBL2017835)
Affinity DataIC50: 71nMAssay Description:Displacement of [125I-CCK] from human CCK1R I6.51V, F6.52Y mutant expressed in CHO cells after 60 mins by scintillation counterMore data for this Ligand-Target Pair
In Depth
Date in BDB:
5/24/2017
Entry Details Article
PubMed
TargetCholecystokinin receptor type A(Rat)
Mayo Clinic

Curated by ChEMBL
LigandPNGBDBM50329179(2-((4S)-4-((1H-indol-3-yl)methyl)-5-oxo-1-phenyl-4...)
Affinity DataIC50: 77nMAssay Description:Displacement of [125I]-BDZ-1 from wild-type rat CCK1R expressed in COS cells after 60 mins by scintillation counterMore data for this Ligand-Target Pair
In Depth
Date in BDB:
5/24/2017
Entry Details Article
PubMed
TargetCholecystokinin receptor type A(Human)
Mayo Clinic

Curated by ChEMBL
LigandPNGBDBM50329179(2-((4S)-4-((1H-indol-3-yl)methyl)-5-oxo-1-phenyl-4...)
Affinity DataIC50: 93nMAssay Description:Displacement of [125I-BDZ-1] from human CCK1R N2.61T mutant expressed in CHO cells after 60 mins by scintillation counterMore data for this Ligand-Target Pair
In Depth
Date in BDB:
5/24/2017
Entry Details Article
PubMed
TargetCholecystokinin receptor type A(Human)
Mayo Clinic

Curated by ChEMBL
LigandPNGBDBM50329179(2-((4S)-4-((1H-indol-3-yl)methyl)-5-oxo-1-phenyl-4...)
Affinity DataIC50: 100nMAssay Description:Agonist activity at human CCK1R W6.48A mutant expressed in CHO cells assessed as intracellular calcium response by fluorescence analysisMore data for this Ligand-Target Pair
In Depth
Date in BDB:
5/24/2017
Entry Details Article
PubMed
TargetCholecystokinin receptor type A(Human)
Mayo Clinic

Curated by ChEMBL
LigandPNGBDBM50380728(CHEMBL2017835)
Affinity DataIC50: 105nMAssay Description:Displacement of [125I-BDZ-1] from human CCK1R N2.61T mutant expressed in CHO cells after 60 mins by scintillation counterMore data for this Ligand-Target Pair
In Depth
Date in BDB:
5/24/2017
Entry Details Article
PubMed
Displayed 1 to 50 (of 99 total ) | Next | Last >>
Jump to: